What is Aclaris Therapeutics's current ratio?

Aclaris Therapeutics (ACRS) reported current ratio of 4× in Q1 2026.

How has Aclaris Therapeutics's current ratio changed year-over-year?

Aclaris Therapeutics's current ratio decreased by 20.4% year-over-year, from 5.1× to 4×.

What is the long-term trend for Aclaris Therapeutics's current ratio?

Over 5 years (2020 to 2025), Aclaris Therapeutics's current ratio has grown at a -2.7% compound annual growth rate (CAGR), from 3.9× to 3.4×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Aclaris Therapeutics ACRS Current ratio

Current ratio at other companies

IncyteINCY

3.7×+1.6×

Corvus PharmaceuticalsCRVS

19.8×+14.9×

Avalo TherapeuticsAVTX

7.7×-14.9×

Shattuck Labs, Inc.STTK

22.1×+13.0×

Apogee Therapeutics, Inc.APGE

32.6×+16.8×

Kymera TherapeuticsKYMR

10.8×+2.3×

Other financials

Income statement

See full

Revenue$2.0M+37.2%

Gross profit$1.6M+68.7%

Operating income-$22.2M-22.7%

Net income-$19.8M-31.4%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$28.7M-5.6%

Total debt$2.0M-20.1%

Total equity$143.6M-0.3%

Total assets$198.7M+0.3%

Cash flow

See full

Operating cash flow-$18.1M-39.0%

CapEx$13.0K-69.8%

Free cash flow-$18.2M-38.6%

Valuation

See full

Market cap$685.75M+337%

Enterprise value$659.07M+410%

P/S82×+73.1×

Profitability

See full

Gross margin76.3%-9.7pp

Operating margin-961.9%+259pp

Net margin-832.6%+132pp

FCF margin-624.9%—

Returns & leverage

See full

Return on equity-48.4%-15.4pp

Debt / equity0×0.0×

Where this comes from

Calculated from Aclaris Therapeutics’s reported figures.

total current assets/total current liabilities=4×

Based on the most recent quarter.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aclaris Therapeutics's current ratio?: Aclaris Therapeutics (ACRS) reported current ratio of 4× in Q1 2026.
How has Aclaris Therapeutics's current ratio changed year-over-year?: Aclaris Therapeutics's current ratio decreased by 20.4% year-over-year, from 5.1× to 4×.
What is the long-term trend for Aclaris Therapeutics's current ratio?: Over 5 years (2020 to 2025), Aclaris Therapeutics's current ratio has grown at a -2.7% compound annual growth rate (CAGR), from 3.9× to 3.4×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.